Blogs, News, & Whitepapers SugarCone Insights Paul Rennert 4/2/24 Paul Rennert 4/2/24 Biotech strategies for an uncertain world Read More Paul Rennert 4/1/24 Paul Rennert 4/1/24 Recent CAR-T clinical studies in glioma and glioblastoma patients Read More Paul Rennert 4/13/23 Paul Rennert 4/13/23 PD-1 versus Car-T: stop making sense It all begins with an idea. Read More Paul Rennert 3/29/23 Paul Rennert 3/29/23 Why aren’t we better at weighing results and making sound conclusions? Read More Paul Rennert 3/1/23 Paul Rennert 3/1/23 Teaching immune cells how to kill Read More Paul Rennert 2/15/23 Paul Rennert 2/15/23 New Horizons Across the Immunotherapy Landscape Read More
Paul Rennert 4/1/24 Paul Rennert 4/1/24 Recent CAR-T clinical studies in glioma and glioblastoma patients Read More
Paul Rennert 4/13/23 Paul Rennert 4/13/23 PD-1 versus Car-T: stop making sense It all begins with an idea. Read More
Paul Rennert 3/29/23 Paul Rennert 3/29/23 Why aren’t we better at weighing results and making sound conclusions? Read More